[go: up one dir, main page]

AR025133A1 - A COMPOSITION OF ANABOLIC IMPLANT TO STIMULATE THE INCREASED SPEED OF GROWTH, USE OF SUCH COMPOSITION FOR THE PREPARATION OF AN IMPLANTANABOLIC TO A LIVESTOCK, AND METHOD FOR PREPARING THE DEVICE WITH THE IMPLANT INTENDED FOR ANIMAL CREATION - Google Patents

A COMPOSITION OF ANABOLIC IMPLANT TO STIMULATE THE INCREASED SPEED OF GROWTH, USE OF SUCH COMPOSITION FOR THE PREPARATION OF AN IMPLANTANABOLIC TO A LIVESTOCK, AND METHOD FOR PREPARING THE DEVICE WITH THE IMPLANT INTENDED FOR ANIMAL CREATION

Info

Publication number
AR025133A1
AR025133A1 ARP990105535A ARP990105535A AR025133A1 AR 025133 A1 AR025133 A1 AR 025133A1 AR P990105535 A ARP990105535 A AR P990105535A AR P990105535 A ARP990105535 A AR P990105535A AR 025133 A1 AR025133 A1 AR 025133A1
Authority
AR
Argentina
Prior art keywords
implant
composition
anabolic
growth
release formulation
Prior art date
Application number
ARP990105535A
Other languages
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR025133A1 publication Critical patent/AR025133A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion de implante anabolico para estimular la velocidad aumentada de crecimiento, mayor cantidad de crecimiento y mayor eficacia de alimentacionen ganado, que comprende: (i) una formulacion de liberacion inmediata que comprende un agente anabolico, y (ii) una formulacion de liberacion controlada quecontiene un agente anabolico y un agente de liberacion controlada, en donde dicha formulacion de liberacion inmediata y dicha formulacion de liberacioncontrolada cooperan para efectuar dichaestimulacion. Un estimulante del crecimiento y del peso mejorado para animales domesticados como ser ganado, cerdo yovejas está compuesto por un agente anabolico que es administrado subcutáneamente en la forma de una formulacion de implante de liberacion dual. Los aumentosincrementados son particularmente mejorados cuando se administra zeranol en una formulacion de liberacion inmediata y de liberacion controlada que permite unainyeccion de dosificacion de una vez. Además, se describe el uso dedicha composicion para la preparacion de un implante anabolico a un ganado, y método parapreparar un dispositivo con el implante destinado a la aplicacion animal para estimular el crecimiento.An anabolic implant composition for stimulating increased growth rate, greater growth and greater efficiency of feeding cattle, comprising: (i) an immediate release formulation comprising an anabolic agent, and (ii) a controlled release formulation which contains an anabolic agent and a controlled release agent, wherein said immediate release formulation and said controlled release formulation cooperate to effect said stimulation. An improved growth and weight stimulant for domesticated animals such as cattle, pigs and sheep is composed of an anabolic agent that is administered subcutaneously in the form of a dual-release implant formulation. Increased increases are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation that allows one-time dosing injection. In addition, the use of said composition for the preparation of an anabolic implant to a cattle is described, and method for preparing a device with the implant intended for animal application to stimulate growth.

ARP990105535A 1998-11-04 1999-11-02 A COMPOSITION OF ANABOLIC IMPLANT TO STIMULATE THE INCREASED SPEED OF GROWTH, USE OF SUCH COMPOSITION FOR THE PREPARATION OF AN IMPLANTANABOLIC TO A LIVESTOCK, AND METHOD FOR PREPARING THE DEVICE WITH THE IMPLANT INTENDED FOR ANIMAL CREATION AR025133A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
AR025133A1 true AR025133A1 (en) 2002-11-13

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105535A AR025133A1 (en) 1998-11-04 1999-11-02 A COMPOSITION OF ANABOLIC IMPLANT TO STIMULATE THE INCREASED SPEED OF GROWTH, USE OF SUCH COMPOSITION FOR THE PREPARATION OF AN IMPLANTANABOLIC TO A LIVESTOCK, AND METHOD FOR PREPARING THE DEVICE WITH THE IMPLANT INTENDED FOR ANIMAL CREATION

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BR9914996A (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
ES3032945T3 (en) 2020-11-19 2025-07-29 Fis Fabbrica Italiana Sintetici Spa Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4000688B1 (en) 2020-11-19 2025-11-05 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (en) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog EXTENDED RELEASE ANABOLIZING IMPLANTS
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
BRPI9914996B8 (en) 2021-07-06
TWI250027B (en) 2006-03-01
WO2000025743A3 (en) 2000-08-24
CO5140100A1 (en) 2002-03-22
WO2000025743A2 (en) 2000-05-11
PE20001092A1 (en) 2000-10-31
AU3096700A (en) 2000-05-22
BRPI9914996A (en) 2001-07-10
MY134868A (en) 2007-12-31
ZA200103494B (en) 2002-07-30
CA2348841A1 (en) 2000-05-11
BRPI9914996B1 (en) 2011-11-01
BR9914996A (en) 2001-07-10
AU777393B2 (en) 2004-10-14
CR6351A (en) 2003-11-20
CA2348841C (en) 2007-04-17

Similar Documents

Publication Publication Date Title
AR045142A1 (en) BUEN SABOR DUCTILE MASTICABLE VETERINARY COMPOSITION
ES2344505T3 (en) ANTIPARASITARY FORMULATIONS.
Rothen-Weinhold et al. Formulation and technology aspects of conrolled drug delivery in animals
EP0990450B1 (en) Pharmaceutical implants
AR098251A2 (en) USE OF AIVLOSIN OR AN ACID ADDITION SALT OF THE SAME PHARMACOLOGICALLY ACCEPTED FOR THE PREPARATION OF A VETERINARY USE MEDICINAL PRODUCT, A FOOD FOR CORRAL BIRDS OR PIGS, A STABLE COVERED COMPOSITION TO BE ADDED TO THIS FOOD
AR025133A1 (en) A COMPOSITION OF ANABOLIC IMPLANT TO STIMULATE THE INCREASED SPEED OF GROWTH, USE OF SUCH COMPOSITION FOR THE PREPARATION OF AN IMPLANTANABOLIC TO A LIVESTOCK, AND METHOD FOR PREPARING THE DEVICE WITH THE IMPLANT INTENDED FOR ANIMAL CREATION
Cardinal et al. Drug delivery in veterinary medicine
JP2005522418A5 (en)
Gardner et al. Efficacy of sublingual administration of detomidine gel for sedation of horses undergoing veterinary and husbandry procedures under field conditions
Rathbone Delivering drugs to farmed animals using controlled release science and technology
ECSP993205A (en) IMPROVED GROWTH STIMULATING COMPOSITIONS (CASE AHO948)
CN110664806B (en) Fipronil and methoprene dihydric alcohol plastid and preparation method and application thereof
ES2992032T3 (en) New method of topical application of veterinary agents
Vandamme et al. Long acting rumen drug delivery systems
Fossler New Products for the Cattle Industry--Compudose 200
Patrizi et al. Generalized reaction to subcutaneous heparin.
CN215839696U (en) Hoof medicated bath device for livestock veterinarian
TH48412A3 (en) Growth stimulant composition That has been updated
RU2438302C2 (en) Method of improving body weight gain of pigs using intensive technology of growing
de Medeiros Feline Injection-Site Sarcoma Complete Remission After Treatment with Isopathic medicine: a Case Report
US20050169966A1 (en) Growth promoting pharmaceutical implant
CN210903495U (en) Poultry animal doctor is with irritating medicine feeder
Kent Veterinary applications
Ferreira Controlling wireworm in spring
AR093734A1 (en) A METHOD TO TREAT LYME'S DISEASE

Legal Events

Date Code Title Description
FG Grant, registration